Acceder Registro /

BRUNO RAMOS MOLINA

Buscador

Lavezzi AM, Ramos-Molina B. Environmental Exposure Science and Human Health. Int J Environ Res Public Health. 2023 May 9;20(10):5764. doi: 10.3390/ijerph20105764. PubMed PMID: 37239493; PubMed Central PMCID: PMC10218044.
AÑO: 2023; IF: 4.614
Ruiz-Alcaraz AJ, Nunez-Sanchez MA, Asensio Ruiz MA, Martinez-Sanchez MA, Oliva-Bolarin A, Martinez Martinez T, Perez Cuadrado JJ, Ramos-Molina B, Lozano-Perez AA. Optimizing the Preparation of Silk Fibroin Nanoparticles and Their Loading with Polyphenols: Towards a More Efficient Anti-Inflammatory Effect on Macrophages. Pharmaceutics. 2023 Jan 12;15(1):263. doi: 10.3390/pharmaceutics15010263. PubMed PMID: 36678894.
AÑO: 2023; IF: 6.525
Khanmohammadi S, Ramos-Molina B, Kuchay MS. NOD-like receptors in the pathogenesis of metabolic (dysfunction)-associated fatty liver disease: Therapeutic agents targeting NOD-like receptors. Diabetes Metab Syndr. 2023 Jun 4;17(7):102788. doi: 10.1016/j.dsx.2023.102788. Online ahead of print. PubMed PMID: 37302383.
AÑO: 2023; IF: 10.0
Marsal-Beltran A, Rodriguez-Castellano A, Astiarraga B, Calvo E, Rada P, Madeira A, Rodriguez-Pena MM, Llaurado G, Nunez-Roa C, Gomez-Santos B, Maymo-Masip E, Bosch R, Frutos MD, Moreno-Navarrete JM, Ramos-Molina B, Aspichueta P, Joven J, Fernandez-Real JM, Quer JC, Valverde AM, Pardo A, Vendrell J, Ceperuelo-Mallafre V, Fernandez-Veledo S. Protective effects of the succinate/SUCNR1 axis on damaged hepatocytes in NAFLD. Metabolism. 2023 Jun 12:155630. doi: 10.1016/j.metabol.2023.155630. Online ahead of print. PubMed PMID: 37315889.
AÑO: 2023; IF: 9.8
Martinez-Sanchez MA, Balaguer-Roman A, Fernandez-Ruiz VE, Almansa-Saura S, Garcia-Zafra V, Ferrer-Gomez M, Frutos MD, Queipo-Ortuno MI, Ruiz-Alcaraz AJ, Nunez-Sanchez MA, Ramos-Molina B. Plasma short-chain fatty acid changes after bariatric surgery in patients with severe obesity. Surg Obes Relat Dis. 2023 Jan 31:S1550-7289(23)00041-2. doi: 10.1016/j.soard.2022.12.041. Online ahead of print. PubMed PMID: 36842931.
AÑO: 2023; IF: 3.1

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R